Compare Bandhan Healthcare Fund vs ICICI Prudential Healthcare Fund
Bandhan Healthcare Fund
EquitySectoral-Pharma
ICICI Prudential Healthcare Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.78
2.07
NAV
₹10.41
₹43.47
Fund Started
10 Nov 2025
25 Jun 2018
Fund Size
₹326.54 Cr
₹6861.20 Cr
Exit Load
Exit load of 0.50%, if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
1 Year
-
-1.65%
3 Year
-
19.02%
5 Year
-
14.15%
Equity
93.55%
98.91%
Cash
6.41%
1.09%
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 9.74% |
Cipla Ltd. | 6.18% |
Apollo Hospitals Enterprise Ltd. | 5.75% |
Max Healthcare Institute Ltd. | 5.27% |
Lupin Ltd. | 4.35% |
Divi's Laboratories Ltd. | 4.27% |
Shilpa Medicare Ltd. | 4.17% |
Aurobindo Pharma Ltd. | 4.10% |
Dr. Reddy's Laboratories Ltd. | 3.78% |
Glaxosmithkline Pharmaceuticals Ltd. | 3.39% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.49% |
Dr. Reddy's Laboratories Ltd. | 9.73% |
Cipla Ltd. | 5.79% |
Biocon Ltd. | 5.33% |
Mankind Pharma Ltd. | 5.04% |
Alkem Laboratories Ltd. | 4.81% |
Medplus Health Services Ltd. | 4.31% |
Cohance Lifesciences Ltd. | 4.06% |
Divi's Laboratories Ltd. | 3.78% |
Syngene International Ltd. | 3.50% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
10 Nov 2025
25 Jun 2018
